Dublin, Ireland, and Mumbai, India and London, United Kingdom--(Newsfile Corp. - February 10, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo ...

Drug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstructive pulmonary disease (COPD), in the UK. COPD is a ...

MUMBAI, Sept 26 (Reuters) - Drug maker Glenmark Pharmaceuticals Ltd said on Wednesday the UK Medicines and Healthcare products Regulatory Agency had approved its semi- solids making plant in Himachal ...

Glenmark Pharmaceuticals announced today that it has received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi, a topical acne treatment. The drug, ...

Glenmark enters collaboration and distribution agreement with Jiangsu Hansoh Pharma for Aumolertinib, a third-generation GFR-TKI to treat NSCLC: Our Bureau, Mumbai Wednesday, Dece ...

Hansoh Pharma will receive an upfront payment of low double-digit million dollars, followed by potential regulatory and ...

Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America. Jiangsu Alphamab and ...

The program will provide nutritional and economic support to over 500 children from the Early Childhood Development (ECD) centres, more than 300 pregnant and lactating women, and over 240 vulnerable ...

Cosmo Pharmaceuticals N.V. (OTCPK:CMOPF) Monday said that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom.